Skip to content
AIPressRoom

FundingHealthcare & Biotech

Relu Lands €1.51M to Accelerate US Expansion

Relu secured €1.51M strategic investment led by Dental Innovation Alliance to accelerate its US market expansion for AI-powered dental design.

Holger Willems, CEO and co-founder of Relu

The big picture: Relu, a Leuven-based AI startup, has announced a €1.51 million ($1.75 million) strategic investment from Dental Innovation Alliance (DIA). The company develops AI solutions to automate dental design and planning, enabling dental labs to scale production.

Why it matters:

  • Addressing Shortages: Relu tackles the deepening shortage of skilled dental technicians by automating manual design and administrative tasks, removing a critical bottleneck in lab production.
  • Scalability: The AI platform allows technicians to handle significantly more cases, boosting productivity and enabling labs to grow without being limited by hiring and training constraints.
  • Strategic Growth: This investment, from a venture capital fund focused on dental and multi-site healthcare, is specifically earmarked to strengthen Relu’s market position in the United States.

How it works:

  • AI-Powered Automation: Relu’s core product, Relu® Automate, is an AI platform that analyzes 3D scans and automatically generates patient-specific designs for various dental appliances, including night guards, surgical guides, and crowns.
  • Streamlined Workflows: The platform eliminates time-consuming manual CAD steps, allowing dental labs to process more cases faster and with consistent quality.
  • Integrated Treatment Planning: For implantology, Relu offers an AI-powered system that automatically generates complete treatment proposals, integrating CBCT segmentation, intraoral scan alignment, implant positioning, and provisional crown design into a unified experience.

The catch: The dental AI market is rapidly expanding, with numerous companies developing solutions for various aspects of dentistry. While Relu boasts strong certifications (CE, FDA 510(k), ISO 13485) and a proven pay-per-case model, it must continuously innovate and demonstrate clear return on investment to maintain its competitive edge against both emerging AI competitors and established traditional workflows in the US market.

Key Facts

  • Company: Relu
  • Amount: €1.51M
  • Round: Strategic
  • Investor: Dental Innovation Alliance (DIA) (lead)
  • Founders: Holger Willems, Adriaan Van Gerven, Antoine Coppens, Thomas Beznik
  • Announced: 2026-08-06
  • Sector: Dental AI Software
  • Headquarters: Leuven, Belgium

Funding Weekly

Every AI funding round we reported last week: the totals, the biggest deals and what they add up to. Weekly · Tuesdays.

More in Healthcare & Biotech

All